Document Detail

Thrombotic thrombocytopenic purpura and cardiac papillary fibroelastoma: a 'unique coexistence'
MedLine Citation:
PMID:  24077148     Owner:  NLM     Status:  Publisher    
Thrombotic thrombocytopenic purpura (TTP), a complex thrombotic microangiopathy, remains an evolving enigma. A 49-year-old African-American woman presented with acute left hemiplegia, an ischemic cerebrovascular accident involving the right middle cerebral artery. Sequential appearance of thrombocytopenia and evidence of microangiopathic haemolysis led to the diagnosis of acquired idiopathic autoimmune TTP. This was managed with plasma exchange (PEX) and steroids. Early haematologic relapse within a month was managed with the addition of rituximab attaining sustained remission. The patient presented 3 years later with acute confusion and expressive aphasia due to multiple infarcts involving the left parieto-occipital cortex. Transoesophageal echocardiography demonstrated a pedunculated 6 mm mitral valvular mass consistent with a papillary fibroelastoma. Anticoagulation was instituted and the patient was continued on therapeutic oral warfarin. A haematologic relapse of TTP eventually emerged and was managed with PEX, steroids and rituximab. This vignette demonstrates several dilemmas in the clinical presentation, diagnosis and management of TTP in current day practice. Rituximab has adjuvant benefits to PEX and is being investigated as potential first-line therapy. Monitoring ADAMTS13 activity and inhibitor titre, as in our case, prove to have prognostic significance. Cardiac fibroelastomas are rare benign cardiac tumours usually arising from valvular endocardium with thromboembolic potential. One of the proposed mechanisms of origin of these masses is organizing thrombi in the setting of endocardial injury and inflammation questioning a possible link to thrombotic microangiopathy. To the best of our knowledge, this is the first report of this unique coexistence.
Praveen Ramakrishnan Geethakumari; Alexander Rubin; Gabor Varadi
Related Documents :
10567328 - Rsr13, a synthetic allosteric modifier of hemoglobin, improves myocardial recovery foll...
7787408 - Amino acid-enriched glucose-insulin-potassium infusion improves hemodynamic function af...
3729178 - Partial cardiopulmonary bypass for core rewarming in profound accidental hypothermia.
16723058 - Myocardial protection by nicorandil during open-heart surgery under cardiopulmonary byp...
24038018 - Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.
801308 - Immunofluorescent and migration inhibition studies in rats with experimental myocardial...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-9-26
Journal Detail:
Title:  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis     Volume:  -     ISSN:  1473-5733     ISO Abbreviation:  Blood Coagul. Fibrinolysis     Publication Date:  2013 Sep 
Date Detail:
Created Date:  2013-9-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9102551     Medline TA:  Blood Coagul Fibrinolysis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
aDepartment of Internal Medicine bDivision of Cardiology cDivision of Hematology-Oncology, Albert Einstein Medical Center, Philadelphia, Pennsylvania, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The big problem: battling companion animal obesity.
Next Document:  Hydrothermal pretreatment of bamboo and cellulose degradation.